JOURNAL PROFILE

ADVANCES IN THERAPY

— · ISSN 0741-238X · 医学-药学

数据可追溯 · letpub-v6 · 更新于 2026-08-24T12:34:44.422Z
实时影响指标4.67
h-index53
平均审稿速度网友分享经验:较慢,6-12周
平均录用比例网友分享经验:较易

ABOUT THE JOURNAL

期刊简介

Advances in Therapy is an international, peer reviewed, rapid-publication (peer review in 2 weeks, published 3–4 weeks from acceptance) journal dedicated to the publication of high-quality clinical (all phases), observational, real-world, and health outcomes research around the discovery, development, and use of therapeutics and interventions (including devices) across all therapeutic areas. Studies relating to diagnostics and diagnosis, pharmacoeconomics, public health, epidemiology, quality of life, and patient care, management, and education are also encouraged.The journal is of interest to a broad audience of healthcare professionals and publishes original research, reviews, communications and letters. The journal is read by a global audience and receives submissions from all over the world. Advances in Therapy will consider all scientifically sound research be it positive, confirmatory or negative data. Submissions are welcomed whether they relate to an international and/or a country-specific audience, something that is crucially important when researchers are trying to target more specific patient populations. This inclusive approach allows the journal to assist in the dissemination of all scientifically and ethically sound research.

STRUCTURED PARTITIONS

学科分区明细

不同版本、大类与小类分别展示,不将不同评价口径合并为一个分区值。

《新锐期刊分区表》( 2026年3月发布)

2026-03 · 3 个学科记录

Top:否综述:N/A
类别学科分区
大类医学2区
小类医学:研究与实验MEDICINE, RESEARCH & EXPERIMENTAL2区
小类药学PHARMACOLOGY & PHARMACY2区

期刊分区表( 2025年3月升级版)

2025-03 · 3 个学科记录

Top:否综述:否
类别学科分区
大类医学3区
小类药学PHARMACOLOGY & PHARMACY2区
小类医学:研究与实验MEDICINE, RESEARCH & EXPERIMENTAL3区

期刊分区表( 2023年12月旧的升级版)

2023-12 · 3 个学科记录

Top:否综述:否
类别学科分区
大类医学3区
小类医学:研究与实验MEDICINE, RESEARCH & EXPERIMENTAL3区
小类药学PHARMACOLOGY & PHARMACY3区

IDENTITY

出版与身份

期刊ISSN
0741-238X
E-ISSN
1865-8652
是否OA开放访问
No
通讯方式
SPRINGER, 233 SPRING ST, NEW YORK, USA, NY, 10013
出版商
Springer Healthcare
出版国家或地区
ENGLAND
出版语言
English
出版周期
Monthly
出版年份
2000

SCOPE

研究范围

期刊简介
Advances in Therapy is an international, peer reviewed, rapid-publication (peer review in 2 weeks, published 3–4 weeks from acceptance) journal dedicated to the publication of high-quality clinical (all phases), observational, real-world, and health outcomes research around the discovery, development, and use of therapeutics and interventions (including devices) across all therapeutic areas. Studies relating to diagnostics and diagnosis, pharmacoeconomics, public health, epidemiology, quality of life, and patient care, management, and education are also encouraged.The journal is of interest to a broad audience of healthcare professionals and publishes original research, reviews, communications and letters. The journal is read by a global audience and receives submissions from all over the world. Advances in Therapy will consider all scientifically sound research be it positive, confirmatory or negative data. Submissions are welcomed whether they relate to an international and/or a country-specific audience, something that is crucially important when researchers are trying to target more specific patient populations. This inclusive approach allows the journal to assist in the dissemination of all scientifically and ethically sound research.
涉及的研究方向
医学-药学

METRICS

指标与活跃度

2025-2026最新IF(数据来源于网友提供)
注册或登录后,查看IF
实时影响因子
截止2026年5月06日:4.67
2025-2026自引率
2.1%点击查看自引率趋势图
五年IF(数据来源于网友提供)
4.596数据由网友[dawnsuperranger]收集提供
h-index
53
CiteScore ( 2026年6月最新版)
CiteScoreSJRSNIPCiteScore排名7.601.4181.585学科分区排名百分位大类:Medicine小类:Pharmacology (medical)Q146 / 278
年文章数
325点击查看年文章数趋势图
Gold OA文章占比
78.29%
研究类文章占比:文章 ÷(文章 + 综述)
78.77%

INDEXING

分区、收录与风险

WOS期刊JCR分区 ( 2025-2026年最新版)
注册或登录后,查看WOS分区等级
期刊分区表预警名单
2026年03月发布的新锐学术版:不在预警名单中2025年03月发布的2025版:不在预警名单中2024年02月发布的2024版:不在预警名单中2023年01月发布的2023版:不在预警名单中2021年12月发布的2021版:不在预警名单中2020年12月发布的2020版:不在预警名单中
SCI期刊收录coverage
Science Citation Index Expanded (SCIE) (2020年1月,原SCI撤销合并入SCIE,统称SCIE)Scopus (CiteScore)
PubMed Central (PMC)链接
访问官方页面 ↗

SUBMISSION

投稿与评审

期刊官方网站
访问官方页面 ↗
期刊投稿网址
访问官方页面 ↗
作者指南网址
访问官方页面 ↗
平均审稿速度
网友分享经验:较慢,6-12周
平均录用比例
网友分享经验:较易

证据与统计

来源:LetPub 原始详情页 ↗。投稿经验仅展示聚合统计,不公开第三方正文或用户标识。当前聚合样本:暂无。